Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
FANTASTIC FIND. How in the world did you come up with it!!!!!
Thanks for the .0005 bid info
Currently 1.6 million shares BID @ .0006. What is the BID size @ .0005?
Lotta "SLAPPING" but not much movement!
MYMD is applying for drug status for its MYMD-1 molecule. The point I was making is that Anatabloc might take sales away from the drug.
A thought occurred to me last night regarding the future availability of Anatabloc. As we know, MYMD Pharmaceuticals is working to establish isomyosmine as a new immunometabolic regulator. Should they be successful and license this technology to others, the licensee would surely insist that Anatabloc not be available as an over the counter competitor.
Thoughts anyone?
How can one determine that the FLOAT is a super tiny 5 million shares?
My fantasy solution, which I have posted once before, is that RCPI, with the agreement of their creditors, filed for Chapter 7 in Sept. 2016 to stop the hemoeraging of share issuance which was occuring under their failed lending agreement. Eventually, MYmd Pharmaceuticals, which was formed as a private company in 2014 and which was filing many patents for isomyosmine would reverse merge with RCPI which had petioned for and was transferred to Chapter 13 status. Upon completion of the merger MYMD would change the name of the company to MyMD Pharmaceuticals and retain the share status of RCPI, exchanging 10 shares of RCPI for 1 share of MyMD. This would leave MyMD Pharma with about 17 million shares outstanding, an ideal balance for a small biotec company with impressive potential. This would also retain as stockholders, investors like myself who had been on board with Star Scientific since before the infamous court case.
How likely that this is actually the case? Not very, but we long suffering RCPI stockholders have learned to live in hope that Jonnie R. Williams Sr. will finally be vidicated.
Check With Tax Advisor
You should check with a qualified tax counselor for what your individual situation will allow. In rare cases, the original stock may retain some value if no new stock is issued and the company comes out of Chapter 11 in sound financial shape. If the company files Chapter 7 bankruptcy, you can be ALMOST certain you have lost all your money invested in the company’s stock.
ALMOST does not mean ABSOLUTELY!!!!!
For those who are following the adventures of RCPIQ and MYMD, a study done by 4 researchers at Johns Hopkins School of Medicine indicated that MYMD-1 ameliorates the course of experimental MS. Add this to similar results achieved with Hashimoto's Thyroiditis. Both studies were done with mice. The latest study concluded, "These results suggest that MYMD-1 may be of interest for evaluating for the treatment of autoimmune diseases".
For many decades medical science believed that the immune system and metabolism were independent systems. Beginning around 2011 cutting edge studies began detecting instances where one of these systems was interacting with the other system. Since then, this has grown into a new area of science now given the new name, immunometabolism, meaning the interaction of the two systems.
The fledgling company, MyMD and its investigational new drug, MyMD-1 appear to be smack dab in the middle of this new science of immunometabolism by treating immunometabolic disfunction which causes disease and aging. MyMB Pharmaceuticals goes on to say that "MyMD-1 is a novel drug platform that is being developed to treat a broad range of conditions, including autoimmune disease, neurological disease and aging by addressing deregulation of the immunometabolic system".
If I am not misunderstanding this, it sounds groundbreaking and a major breakthrough in the treatment of disease!
The bidders still seem to have the upper hand!
I see the link to the Trademark site is not working, so here is a correction. The "WORD MARK" MyMD-1 has been applied for, but not yet issued.
It is described as "Preparations for reversing the effects of aging".
Isomyosmine molecule has received a trademark!
http://tmsearch.uspto.gov/bin/showfield?f=doc&state=4808:hhuwe3.2.1
As I said in message #29943 there seem to be an awful lot of shares available for sale which do not show up on the Level 2 ASK. These are probably the flood of shares issued under the disastrous lending agreement that forced RCPI to declare Chapter 7.
This does not bode well for those still holding RCPIQ shares, but it does bring up the question of why there are buyers at all at .0007!!!!!
The control over prices at which shares trade still seems to be in the bidder's hands, as sellers seem to be willing to let shares go at give away prices. What does this mean to shareholders who continue to hang onto their RCPIQ shares?
Who knows!
For anyone who has the stomach for it the link below is to the patent applied for by Jonnie Williams and assigned to MYMD Pharmaceuticals entitled "Methods of Treating Apoptosis and Altering Programmed Cell Death".
Under "Summary" it lists 184 items that seem to say everything that could be said about the nicotinic molecules and their potential for treating a mind blowing number of diseases and medical conditions, many of which have no current treatment option. I finally undertook to read the entire patent and am blown away by the audacity of its claims should they ever be proven valid through thorough testing. https://patents.google.com/patent/US20180021321A1/en?inventor=Jonnie+Williams&assignee=Mymd+Pharmaceuticals%2c+Inc.
The ball remains in Jonnie Williams' court as we not so patiently await an announcement of the FDA Phase 1 results and the plan for the FDA Phase 2 MYMD-1 vs Hashimoto's Thyroiditis bout. Perhaps this will come with the reopening of the MYMD Pharmaceuticals website.
The folks at MYMD are probably getting all their ducks in a row in the expectation that MYMD-1 will be the winner in the Phase 2 results. It is my hope that MYMD Pharma would then select an international pharmaceutical company for a worldwide exclusive license to develop isomyosmine molecules for all other Autoimmune System Diseases. Such an agreement would include upfront license fees and a reasonable royalty agreement on eventual sales.
We continue to live in hope especially since MYMD Pharma has said they are working on molecules for a broad range of conditions including cardiovascular disease, neurological disease, and aging.
Looks like a lot of shares available for sale that are not showing up on level 2 ASK.
3 1/4 million shares traded with a high of .001! Seems like the pressure is to sell shares with the buyer taking all shares being offered at .001!
Looks like the bidder is running the show here with 360k offered at .0009, and only 20k bid at .0008!
Someone snatched up 80k at .0012 at the close!
Thank you for your valuable contribution!
NO "SLAPPING" GOING ON HERE TODAY!
Anatabloc is about to be bypassed by isomyosmine as MYMD Pharmaceuticals will soon begin a phase 2 FDA study testing it against Hashimoto's Thyroiditis. Should the test be a success, which is very likely, Jonnie will have blown the roof off of the pharmaceutical industry as it will mean he has tamed the ever elusive untreatable immune system diseases.
MYMD has previously announced that it is preparing 4 "preclinical studies focused on additional age-related diseases, virtually all autoimmune diseases, Alzheimer's disease, various cancers and heart disease'.
Once again someone was willing to buy over 300k shares, this time @ .ooo9.
A quick look at the trading since the Chapter 7 shows that by far the bulk of the trades were at .001 or less, and there always seemed to be large volume bids in the .0006 and .0007 range.
Comments anyone?
After spending a significant amount of time searching the internet I was unable to find anything relating to a corporation exiting a Chapter 7 Bankruptcy filing. Unless someone can give us the name of a corporation that has done so, I am assuming it can't be done, as we have been told repeatedly.
However, as I said earlier, it is possible that MYMD Pharma had made an agreement with RCPI's major creditors to exchange their shares in RCPI for shares in MYMD Pharma when it became a public corporation, on an agreed to equitable basis such as 1 for 10, 1 for 100, or 1 for 1,000.
Comments?
I would like to offer another view on this discussion because of the cozy relationship between RCPIQ and MYMD Pharmaceutical.
MYMD Pharma was incorporated in Florida in Nov. 2014, almost 2 years before the RCPI Chapter 7. There is a possibility that when RCPI got into financial difficulties over a financing arrangement that resulted in a hemorrhaging of stock share issuing, they came to an agreement with the creditor over what we see now.
They could have agreed on stopping the share issuance with a Chapter 7, and proceed with whatever agreement they both felt was equitable to both parties.
However, only time will tell, but we may know when MYMD Pharmaceuticals resumes its website!
VALUE
Does Stock Killers World have any opinion on RCPIQ?
Your question about the relationship between MYMD and RCPI hasn't been answered so I'll just say that the individual behind RCPI, Jonnie Williams, also started MYMD. I have expected for some time that MYMD would reverse merge into RCPI, thereby taking MYMD public without all the expense and effort usually required.
Jonnie Williams has struggled mightily to bring the nicotinic molecules to market for their seemingly awesome health benefits, but this time he seems to have gotten it right, and hopefully it will earn him a Nobel prize.
NOW WHAT DO WE SAY?
Fantastic detective work! Thanks for sharing.
Always appreciate your input. I have some shares they can have when they are willing to pay .06 for them!
I have long wondered if what we have been seeing here in RCPIQ trades, are trades by independent bidders and buyers, or are a lot of these trades being done by a group which has been accumulating shares.
WE have seen at times, many shares trade at a higher price, then a few shares trade near closing, at a lower price, or unchanged for the day leaving the impression that not much happened!
Thanks again for your input, but I think a lot depends on what MYMD Pharma does when their website comes back online.
What DD could you have on a company that had ceased to exist 3 years ago?
I do know just about everything that is publicly known about RCPI and MYMD, but I don't know their future! Only time will tell!
Someone is willing to buy 3 1/4 million shares of RCPIQ at $.ooo6 or $600 per million and the stock will be worthless soon???? Doesn't make sense!
This "hidden gem" is probably selling at a "Giant discount" because this board's administrator has said repeatedly that the shares will soon be worthless, which makes one wonder why anyone would be on the BUY side.
MYMD has said that Phase 1 testing would be completed in 2019.
DITTO!
But I think we may be reaching a conclusion, with MYMD Pharma nearing the end of its Phase 1 and redoing its website. Can only hope it works out well for RCPIQ shareholders.